Hepatitis B Virus and 2 β-Microglobulin Concentration in Individuals Living with Human Immune Deficiency Virus in South West Nigeria
Hepatitis B virus (HBV) is a major health concern with people leaving with HIV/AIDS. However, not much have associated HBV with increase in 2β-microglobulin (2βM) concentration in people living with HIV/AIDS in sub-saharan Africa though is a tumor marker.
Materials and Methods
Blood sample (n=435) were collected from individuals attending various HIV screening centres in South west Nigeria after the exclusion of individuals testing positive to tuberculosis, Hepatitis C virus (HCV), Human papilloma virus (HPV), (all tested by ELISA technique) typhoid and malaria. Of the 435 individuals selected for the study, 110 were positive for HIV alone, 217 for HIV and HBV while 108 were mono-infected with HBV. All individuals were tested for 2MG using the quantitative ELISA technique.
There was a significant increase in 2MG concentration among those infected with HIV and HBV as opposed to the low levels in mono-infected individuals when compared to the normal concentration of 2βM in healthy individuals.
The elevated level of 2βM in HIV coinfection with HBV as compared to the mono-infected individuals and normal concentration, is indicative of the fact that infection with HBV in HIV infected individuals may have caused the elevated 2βM in the co-infected individuals. This go to confirm that the risk of developing hepatocellular carcinoma and cirrhosis as well as other related diseases is higher in co-infected individuals. Thereby confirming that HBV is a risk factor to carcinoma in people living with HIV.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).